-+ 0.00%
-+ 0.00%
-+ 0.00%

MOLECULIN BIOTECH - MIRACLE TRIAL REPORTS 37% BLINDED CRC IN VENETOCLAX-FAILED R/R AML PATIENTS - SEC FILING

路透·07/31/2026 12:06:14

登录查看新闻详情